<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: antiviral</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'antiviral'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22antiviral%22&t=%22antiviral%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:16:11 +0100</lastBuildDate>
        <item>
            <title>TWiV 146: Draco’s potion</title>
            <link>http://www.medworm.com/index.php?rid=5174216&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FrmUugv8zTgM%2F</link>
            <description>Hosts: Vincent Racaniello, Rich Condit, and Abbie Smith
Vincent, Rich, and Abbie review a broad spectrum antiviral protein, and selective pressure applied by a failed HIV-1 vaccine.

Click the arrow above to play, or right-click to download TWiV 146 (78 MB .mp3, 107 minutes).
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:

Broad spectrum antiviral (PLoS One)
Selection by failed HIV-1 vaccine (Nature Medicine)
HIV vaccine impacts virus (EurekAlert!)
TWiV on Facebook
Letters read on TWiV 146

Weekly Science Picks
Vincent - Hypothetical Risk: Cambridge City Council&amp;#8217;s Hearings on Recombinant DNA Research
Rich &amp;#8211; Z Corporation 3-D printer (YouTube)
Listener ...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5174216</comments>
            <pubDate>Sun, 28 Aug 2011 20:46:30 +0100</pubDate>
            <guid isPermaLink="false">5174216</guid>        </item>
        <item>
            <title>7 Good Reasons to Cry: The Healing Property of Tears</title>
            <link>http://www.medworm.com/index.php?rid=4876419&amp;cid=t_236055_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F05%2F29%2F7-good-reasons-to-cry-the-healing-property-of-tears%2F</link>
            <description>New York Times reporter Benedict Carey referred to tears in a piece as &amp;#8220;emotional perspiration.&amp;#8221; Given that I sweat a lot and hate deodorant, I suppose it makes sense that I weep often. But I&amp;#8217;m not going to apologize for that, because after a good cry, I always feel cleansed, like my heart and mind just rubbed each other&amp;#8217;s backs in a warm bath. 
In his intriguing article, &amp;#8220;The Miracle of Tears&amp;#8221;, from which I&amp;#8217;ve borrowed some of the research for this post, author Jerry Bergman writes: &amp;#8220;Tears are just one of many miracles which work so well that we taken them for granted every day.&amp;#8221; Here, then, are seven ways tears and the phenomenon we call &amp;#8220;crying&amp;#8221; heal us physiologically, psychologically, and spiritually.

1. Tears help us ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4876419</comments>
            <pubDate>Sun, 29 May 2011 10:58:25 +0100</pubDate>
            <guid isPermaLink="false">4876419</guid>        </item>
        <item>
            <title>TWiV 130: Rhino tracking, wrestling pox, and HCV in the crosshairs</title>
            <link>http://www.medworm.com/index.php?rid=4747270&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2F9ScghR9Ji_c%2F</link>
            <description>Hosts: Vincent Racaniello, Alan Dove, and Rich Condit
Vincent, Alan, and Rich discuss growth in culture of newly identified rhinovirus C, vaccinia transmission among wrestlers and martial artists, and results of phase III clinical trial of boceprevir, a new inhibitor of hepatitis C virus replication.

Click the arrow above to play, or right-click to download TWiV #130 (45 MB .mp3, 93 minutes).
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:

Growth of newly identified rhinovirus C (Nature Medicine)
Global distribution of rhinovirus C (EID)
Vaccinia transmission among wrestlers (EID)
Vaccine transmission in a martial arts gym (EID)
Boceprevir for untreated HCV in...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4747270</comments>
            <pubDate>Sun, 24 Apr 2011 14:40:35 +0100</pubDate>
            <guid isPermaLink="false">4747270</guid>        </item>
        <item>
            <title>TWiV 121: Huskies go viral</title>
            <link>http://www.medworm.com/index.php?rid=4636109&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ftraffic.libsyn.com%2Ftwiv%2FTWiV121.mp3</link>
            <description>Hosts: Vincent Racaniello, Michael Katze, Michael Gale, Deborah Fuller, and Shawn Iadonato
Episode #121 of the podcast This Week in Virology is a conversation about careers in virology, systems biology, innate immunity, and antiviral research recorded at the University of Washington in Seattle.
Download TWiV #121 (65 MB .mp3, 90 minutes). To download, right-click or control-click on the link, then select save as.
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:

 A systems biology approach to infectious disease research (mBio)
Infectious Curiosity (thanks, Gopal!)
Astronomy Cast (thanks, Jacob!)
The Journal of Negative Results (thanks, Patricia!)
Scientist Solutions...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4636109</comments>
            <pubDate>Sun, 20 Feb 2011 23:23:10 +0100</pubDate>
            <guid isPermaLink="false">4636109</guid>        </item>
        <item>
            <title>Reductions in Drinking for Hep C Patients</title>
            <link>http://www.medworm.com/index.php?rid=4025781&amp;cid=t_236055_151_f&amp;fid=35805&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Ftwelvestepfacilitation%2FwAgT%2F%7E3%2Fca7eOYibSuM%2F</link>
            <description>DISCUSSION: Brief treatment addressing heavy drinking delivered by hepatitis clinicians with psychiatric-specialist follow-up was associated with abstinence or a significant reduction in alcohol consumption in over 50% of patients.
Eric Dieperink, M.D., Samuel B. Ho, M.D., Sara Heit, M.S., R.N., C.N.S., Janet M. Durfee, R.N., M.S.N., APRN, Paul Thuras, Ph.D., and Mark L. Willenbring, M.D. Psychosomatics 51:149-156, March-April 2010

See also
Hepatitis C – Does sexual transmission occur?
Counselor Magazine&amp;#8217;s Addiction Professional Reference Guide
Disturbing Denial
Improving Treatment Compliance
Wernicke-Korsakoff Syndrome

Random ArticlesRecovering Alcoholics Effective in Helping OthersFamilies, mental health &amp;#038; alcohol abuseAlcohol Across the LifespanBrief-TSF DescriptionPrinci...</description>
            <author>Twelve Step Facilitation.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4025781</comments>
            <pubDate>Thu, 30 Sep 2010 07:04:14 +0100</pubDate>
            <guid isPermaLink="false">4025781</guid>        </item>
        <item>
            <title>TWiV 99: ICAAC Boston 2010</title>
            <link>http://www.medworm.com/index.php?rid=3983290&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmwvideo.s3.amazonaws.com%2FICAAC-TWiV%2FTWiV99.wmv</link>
            <description>Host: Vincent Racaniello
Vincent tours the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, speaking with exhibitors and visitors, including Professors Derek Smith, Michael Schmidt, Frederick Hayden, and Myra McClure.
Many thanks to Chris Condayan and Ray Ortega of the American Society for Microbiology for recording and editing this episode.
Download TWiV #99 (45 MB .mp3, 62 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.
Links for this episode:

50th ICAAC
ICAAC daily press conference videos (including Prof. Myra McClure)
Antigenic cartography
Antimicrobial properties of copper
Video of this episode – download .mp4 (1.99 GB) or .wmv (935 MB...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3983290</comments>
            <pubDate>Mon, 20 Sep 2010 02:58:30 +0100</pubDate>
            <guid isPermaLink="false">3983290</guid>        </item>
        <item>
            <title>TWiV 92: Live at ASV in Bozeman</title>
            <link>http://www.medworm.com/index.php?rid=3786877&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmedia.rawvoice.com%2Fpmn_twiv%2Fwww.twiv.tv%2FTWiV092.mp3</link>
            <description>Hosts: Vincent Racaniello, Rich Condit, Karla Kirkegaard, and Marilyn Roosinck
On episode #92 of the podcast This Week in Virology, Vincent, Rich, Karla, and Marilyn recorded TWiV at the 29th Annual Meeting of the American Society for Virology in Bozeman, where they discussed plant viruses and how they make plants resistant to adverse conditions, and identification of dominant negative drug targets.
Download TWiV #92 (42 MB .mp3, 57 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.
Links for this episode:

Lifestyles of plant viruses
Using pyrosequencing to understand virus ecology
A virus in a fungus in a plant
Trans-dominant inhibition of RNA viral replication
Resistance is futile
Anno...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3786877</comments>
            <pubDate>Sun, 25 Jul 2010 15:12:33 +0100</pubDate>
            <guid isPermaLink="false">3786877</guid>        </item>
        <item>
            <title>A new target for hepatitis C virus</title>
            <link>http://www.medworm.com/index.php?rid=3648231&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fwww.virology.ws%2Ffib60.mp3</link>
            <description>When infection with hepatitis C virus goes from acute to chronic, severe liver disease may occur which requires organ transplantation. Nearly 200 million people are chronically infected with HCV, necessitating approaches to preventing and treating infections. No HCV vaccine is available, and current antiviral therapy consists of administration of interferon plus ribavirin, a combination that is effective about half the time and is associated with undesirable side effects. New antiviral compounds that target a viral protease and RNA polymerase are currently in clinical trials may eventually reach the market. But our experience with HIV-1 has shown that combinations of three drugs are the most effective for derailing the emergences of drug resistant viruses. The third target for HCV could be...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3648231</comments>
            <pubDate>Wed, 09 Jun 2010 16:17:13 +0100</pubDate>
            <guid isPermaLink="false">3648231</guid>        </item>
        <item>
            <title>TWiV 85: Hepatitis C virus with Professor Michael Gale</title>
            <link>http://www.medworm.com/index.php?rid=3635504&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmedia.rawvoice.com%2Fpmn_twiv%2Fwww.twiv.tv%2FTWiV085.mp3</link>
            <description>Hosts: Vincent Racaniello and Michael Gale
On episode 85 of the podcast This Week in Virology, Vincent and Michael Gale discuss the origin, pathogenesis, prevention, of hepatitis C virus, and how it evades innate immune responses.
This episode is sponsored by Data Robotics Inc. Use the promotion code TWIVPOD to receive $75-$500 off a Drobo.
Download TWiV #85 (40 MB .mp3, 56 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email, or listen on your mobile device with Stitcher Radio.
Links for this episode:

The Gale Laboratory at the University of Washington
Incredible view from the Gale laboratory (jpg)
Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses (review)
New potent HCV inhibitor
HCV virion and genome s...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3635504</comments>
            <pubDate>Sun, 06 Jun 2010 15:33:31 +0100</pubDate>
            <guid isPermaLink="false">3635504</guid>        </item>
        <item>
            <title>Futures in Biotech 60: Do you come to this cave often?</title>
            <link>http://www.medworm.com/index.php?rid=3595350&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fwww.podtrac.com%2Fpts%2Fredirect.mp3%2Ftwit.cachefly.net%2Ffib0060.mp3</link>
            <description>I joined Marc Pelletier on episode 60 of Futures in Biotech for a conversation with Dave Brodbeck, George Farr, and Andre Nantel. We talked about primate face recognition, discovery of a new antiviral compound to treat hepatitis C virus infection, changing the length of a codon from three to four bases, and the sequence of the neanderthal genome.
Download FiB #60 (44 MB .mp3, 91 minutes)
Video courtesy of Team ODTV
				
				
Download video (179 MB .mp4) (Source: virology blog)</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3595350</comments>
            <pubDate>Tue, 25 May 2010 10:38:37 +0100</pubDate>
            <guid isPermaLink="false">3595350</guid>        </item>
        <item>
            <title>Virology lecture #21: Antivirals</title>
            <link>http://www.medworm.com/index.php?rid=3542264&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fwww.virology.ws%2F021_W3310_10.wmv</link>
            <description>Download: .wmv (349 MB) | .mp4 (90 MB)
Visit the virology W3310 home page for a complete list of course resources. (Source: virology blog)</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3542264</comments>
            <pubDate>Fri, 07 May 2010 14:37:27 +0100</pubDate>
            <guid isPermaLink="false">3542264</guid>        </item>
        <item>
            <title>Inhibitors of XMRV</title>
            <link>http://www.medworm.com/index.php?rid=3443512&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FHyz-u3g1UBE%2F</link>
            <description>Xenotropic murine leukemia virus related virus (XMRV) has been implicated in prostate cancer and chronic fatigue syndrome (CFS). Because XMRV is a retrovirus, it might be susceptible to antiviral drugs that are licensed for the treatment of AIDS. AZT (azidothymidine) was previously found to block XMRV replication. A screen of forty-five compounds reveals that XMRV replication is inhibited by raltegravir and three other drugs.
The authors studied the effect of 45 compounds on the replication of XMRV in cell lines derived from human breast (MCF-7) and prostate (LNCaP) cancers. Twenty-eight of the drugs have been approved for use in humans, including treatment of HIV-1 infection. The drugs tested include nucleoside and non-nucleoside reverse-transcriptase inhibitors, and integrase and proteas...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3443512</comments>
            <pubDate>Wed, 07 Apr 2010 15:44:48 +0100</pubDate>
            <guid isPermaLink="false">3443512</guid>        </item>
        <item>
            <title>Reductions in Drinking for Hep C Patients</title>
            <link>http://www.medworm.com/index.php?rid=3408640&amp;cid=t_236055_151_f&amp;fid=35805&amp;url=http%3A%2F%2Ftwelvestepfacilitation.com%2Freductions-in-drinking-for-hep-c-patients%2F</link>
            <description>DISCUSSION: Brief treatment addressing heavy drinking delivered by hepatitis clinicians with psychiatric-specialist follow-up was associated with abstinence or a significant reduction in alcohol consumption in over 50% of patients.
Eric Dieperink, M.D., Samuel B. Ho, M.D., Sara Heit, M.S., R.N., C.N.S., Janet M. Durfee, R.N., M.S.N., APRN, Paul Thuras, Ph.D., and Mark L. Willenbring, M.D. Psychosomatics 51:149-156, March-April 2010

See also
Hepatitis C – Does sexual transmission occur?
Counselor Magazine&amp;#8217;s Addiction Professional Reference Guide
Disturbing Denial
Improving Treatment Compliance
Wernicke-Korsakoff Syndrome


Related Reading:




       Share/SaveRandom ArticlesPatient Mental Illness in a Dental School ClinicComorbid anxiety or alcohol disorderAA and recovery from alc...</description>
            <author>Twelve Step Facilitation.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3408640</comments>
            <pubDate>Fri, 26 Mar 2010 09:34:46 +0100</pubDate>
            <guid isPermaLink="false">3408640</guid>        </item>
        <item>
            <title>TWiV #70: Hacking aphid behavior</title>
            <link>http://www.medworm.com/index.php?rid=3301989&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fmedia.rawvoice.com%2Fpmn_twiv%2Fwww.twiv.tv%2FTWiV070.mp3</link>
            <description>Hosts: Vincent Racaniello, Dickson Despommier, and Alan Dove
On episode #70 of the podcast &amp;#8216;This Week in Virology&amp;#8217;, Vincent, Dickson, and Alan consider a broad spectrum antiviral against enveloped viruses, how a plant virus induces chemical signals in the host to maximize its spread, a new way to preserve viral vaccines at tropical temperatures, and the continuing story of XMRV and chronic fatigue syndrome.
This episode is sponsored by Data Robotics Inc. Use the promotion code VINCENT to receive $50 off a Drobo or $100 off a Drobo S.
Win a free Drobo S! Contest rules here.
Download TWiV #70 (56 MB .mp3, 77 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email.
Links for this episode:

Broad spectrum antiviral against enveloped virus...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3301989</comments>
            <pubDate>Sun, 21 Feb 2010 23:50:04 +0100</pubDate>
            <guid isPermaLink="false">3301989</guid>        </item>
        <item>
            <title>An antiviral for enveloped viruses</title>
            <link>http://www.medworm.com/index.php?rid=3287419&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FKsK0AgKil_M%2F</link>
            <description>Broad spectrum antibiotics are available that act against a wide range of bacteria, including both gram-positive and gram-negative species. In contrast, our antiviral arsenal is exceedingly specific. Nearly all the known antivirals block infection with one or two different viruses. The discovery of a compound that blocks infection with many different enveloped viruses may change the landscape of antiviral therapy.
A small molecule has been discovered that inhibits infection by a wide range of viruses with membranes, the so-called enveloped viruses. The compound, called LJ001, is a derivative of aryl methylene rhodanine. It was discovered in a search for compounds that block the entry of Nipah virus into cells. LJ001 was then found to block infection of cells by a wide variety of enveloped ...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3287419</comments>
            <pubDate>Thu, 18 Feb 2010 22:59:23 +0100</pubDate>
            <guid isPermaLink="false">3287419</guid>        </item>
        <item>
            <title>Influenza neuraminidase inhibitors work</title>
            <link>http://www.medworm.com/index.php?rid=3118627&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2F-I4k-Kd0LyQ%2F</link>
            <description>In the wake of a British Medical Journal article which concludes that Tamiflu has at best a modest effect, many readers have asked if influenza neuraminidase inhibitors function at all. If you&amp;#8217;d like a good critique of this study, I suggest reading Paul Revere&amp;#8217;s analysis of the at Effect Measure. For our part, we&amp;#8217;ll examine some of the virological evidence for the effectiveness of Tamiflu.
One of the first human studies on the effectiveness of Tamiflu was published about ten years ago. The human subjects (117 healthy adult volunteers, 18-40 years of age, with hemagglutination-inhibition antibody titers 1:8 or lower) were infected intranasally with a seasonal H1N1 strain of influenza virus. Some subjects were given Tamiflu or placebo 26 hours before infection, while others...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3118627</comments>
            <pubDate>Wed, 23 Dec 2009 20:40:12 +0100</pubDate>
            <guid isPermaLink="false">3118627</guid>        </item>
        <item>
            <title>Rhinovirus and zinc part 4: cell toxicity</title>
            <link>http://www.medworm.com/index.php?rid=3082218&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2F6aCAHqnXJj8%2F</link>
            <description>My experiments to understand how ZnCl2 inhibits rhinovirus replication have been thwarted by the finding that concentrations of the salt higher than 0.1 mM are toxic for cultured HeLa cells. The cells can tolerate 0.1 mM but not 0.2 mM ZnCl2. Last week I asked whether I could identify a concentration between 0.1 and 0.2 mM that does not harm the cells but inhibits viral plaque formation &amp;gt;99%. Here are the results.


Unfortunately even 0.125 mM ZnCl2 is toxic to the cells &amp;#8211; which is surprising since the cells can tolerate 0.1 mM. The goal of these experiments is to identify Zn-resistant rhinovirus mutants, and this cannot be done with cell monolayers that are not healthy.
I have one more idea for how to get around the ZnCl2 toxicity. To improve the formation of rhinovirus plaques, ...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3082218</comments>
            <pubDate>Fri, 11 Dec 2009 22:18:29 +0100</pubDate>
            <guid isPermaLink="false">3082218</guid>        </item>
        <item>
            <title>Zinc and rhinovirus replication</title>
            <link>http://www.medworm.com/index.php?rid=3022729&amp;cid=t_236055_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2F1LdQplUyGXQ%2F</link>
            <description>Recently I began experiments to understand how zinc inhibits rhinovirus replication, and I promised to document my findings on the pages of this blog. Here are the results of the second plaque assay.
In the last experiment I confirmed the finding that 0.1 mM ZnCl2 inhibits plaque formation by rhinovirus type 1A. Based on the results of that plaque assay, shown in the figure at left, I&amp;#8217;ve decided that this concentration of zinc isn&amp;#8217;t sufficient to completely inhibit viral replication. Although 0.1 mM ZnCl2 blocked plaque formation when 20 or 200 pfu were inoculated on cells, many plaques arose on plates inoculated with 2000 pfu. These cannot be viral mutants resistant to zinc &amp;#8211; there are too many of them. If there are 2000 plaques on the untreated plate, and 200 on the pla...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3022729</comments>
            <pubDate>Mon, 23 Nov 2009 17:27:58 +0100</pubDate>
            <guid isPermaLink="false">3022729</guid>        </item>
        <item>
            <title>Pandemic 101 - a Primer</title>
            <link>http://www.medworm.com/index.php?rid=2473600&amp;cid=t_236055_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FotUBjGxgNb0%2F</link>
            <description>You&amp;#8217;ve likely heard by now. After weeks of hesitating, the World Health Organization has declared the H1N1 virus infections to be a Level 6 on the pandemic scale, which means a pandemic has been announced. The thing is, your life is still the same. My life is still the same. Nothing has changed from the five minutes before the announcement and five minutes after the announcement. That&amp;#8217;s what people need to remember before beginning to panic.
Here is some information that may help you learn more about pandemics, viruses, etc.
What&amp;#8217;s the difference between a pandemic and an epidemic?
 An epidemic is something that can happen anywhere, any time with just about any type of contagious situation. Last year, there were some epidemics of mumps in some universities, a few years ag...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2473600</comments>
            <pubDate>Fri, 12 Jun 2009 00:46:17 +0100</pubDate>
            <guid isPermaLink="false">2473600</guid>        </item>
        <item>
            <title>7 Good Reasons To Cry Your Eyes Out</title>
            <link>http://www.medworm.com/index.php?rid=2458164&amp;cid=t_236055_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F06%2F06%2F7-good-reasons-to-cry-your-eyes-out%2F</link>
            <description>New York Times reporter Benedict Carey referred to tears in a recent piece as &amp;#8220;emotional perspiration.&amp;#8221; Given that I sweat a lot and hate deodorant, I suppose it makes sense that I weep often. But I&amp;#8217;m not going to apologize for that, because after a good cry, I always feel cleansed, like my heart and mind just rubbed each other&amp;#8217;s backs in a warm bath. 
In his intriguing article, &amp;#8220;The Miracle of Tears&amp;#8221; , from which I&amp;#8217;ve lifted some of the research for this post, author Jerry Bergman writes: &amp;#8220;Tears are just one of many miracles which work so well that we taken them for granted every day.&amp;#8221; Here, then, are seven ways tears and the phenomenon we call &amp;#8220;crying&amp;#8221; heal us physiologically, psychologically, and spiritually.
1. Tears hel...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2458164</comments>
            <pubDate>Sat, 06 Jun 2009 11:10:33 +0100</pubDate>
            <guid isPermaLink="false">2458164</guid>        </item>
        <item>
            <title>Development of New Anti-Orthopoxvirus Drugs</title>
            <link>http://www.medworm.com/index.php?rid=2424365&amp;cid=t_236055_132_f&amp;fid=37823&amp;url=http%3A%2F%2Fathena.bioc.uvic.ca%2Fnode%2F1027</link>
            <description>In this study the researchers identified a peptide aptamer 72 that binds to a central domain on A20 - a major component of the vaccinia virus replication complex. It was shown that vaccinia virus DNA synthesis was impaired in cells constitutively expressing peptide aptamer 72 and that the virus production was inhibited in those cells.
read more (Source: VBRC Blog)</description>
            <author>VBRC Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2424365</comments>
            <pubDate>Wed, 20 May 2009 21:46:44 +0100</pubDate>
            <guid isPermaLink="false">2424365</guid>        </item>
        <item>
            <title>H1N1 Flu and Antiviral Drugs</title>
            <link>http://www.medworm.com/index.php?rid=2414794&amp;cid=t_236055_93_f&amp;fid=36982&amp;url=http%3A%2F%2Fprep4md.blogspot.com%2F2009%2F05%2Fh1n1-flu-and-antiviral-drugs.html</link>
            <description>This podcast discusses the use of antiviral drugs for treating and preventing the H1N1 flu virus.Thanks for reading :)

...

http://prep4md.blogspot.com/ (Source: My M.D. Journey!)</description>
            <author>My M.D. Journey!</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2414794</comments>
            <pubDate>Sat, 16 May 2009 22:28:00 +0100</pubDate>
            <guid isPermaLink="false">2414794</guid>        </item>
        <item>
            <title>Guidance on Swine Flu and Breastfeeding</title>
            <link>http://www.medworm.com/index.php?rid=2382285&amp;cid=t_236055_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fwww.blisstree.com%2Fbreastfeeding123%2Fguidance-on-swine-flu-and-breastfeeding%2F</link>
            <description>Both the Centers for Disease Control and Prevention (CDC) and the United States Breastfeeding Committee (USBC) have issued strong guidance on the importance of breastfeeding for protection against the H1N1 swine flu. The CDC states, &amp;#8220;Infants who are not breastfeeding are particularly vulnerable to infection and hospitalization for severe respiratory illness.&amp;#8221; Photo courtesy of Furya
Thus, the CDC urges new mothers to initiate breastfeeding early and to feed frequently. Mothers already breastfeeding should continue to do so, even if they become ill. Formula feeding should be avoided or minimized and breastfeeding maximized. In the Health News Digest, USBC Chair Joan Younger Meek, MD, MS, RD, FAAP, FABM, IBCLC, recommends breastfeedng in emergency situations such as a swine flu o...</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2382285</comments>
            <pubDate>Sat, 02 May 2009 05:55:40 +0100</pubDate>
            <guid isPermaLink="false">2382285</guid>        </item>
        <item>
            <title>HCV Antiviral Biotech Race</title>
            <link>http://www.medworm.com/index.php?rid=2349276&amp;cid=t_236055_132_f&amp;fid=37823&amp;url=http%3A%2F%2Fathena.bioc.uvic.ca%2Fnode%2F998</link>
            <description>Chronic hepatitis C is the most common blood-borne infection in the US and is four times more common than HIV. An estimated 170 million people worldwide—3% of the global population—are infected, and up to 4 million acquire the infection each year. To eliminate detectable virus from the blood, current standard of care for hepatitis C patients is a combination of PEG-IFN-&amp;alpha; and ribavirin, a nucleoside analog with antiviral activity.
read more (Source: VBRC Blog)</description>
            <author>VBRC Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349276</comments>
            <pubDate>Fri, 17 Apr 2009 00:30:04 +0100</pubDate>
            <guid isPermaLink="false">2349276</guid>        </item>
        <item>
            <title>What You Should Know About Acyclovir For Treating Primary Herpetic Gingivostomatitis</title>
            <link>http://www.medworm.com/index.php?rid=2022775&amp;cid=t_236055_125_f&amp;fid=37825&amp;url=http%3A%2F%2Fbibbynews.wordpress.com%2F2008%2F12%2F08%2Fwhat-you-should-know-about-acyclovir-for-treating-primary-herpetic-gingivostomatitis%2F</link>
            <description>The Cochrane Collaboration recently published a review evaluating the effectiveness of systemic acyclovir for primary herpetic gingivostomatitis.
Preparation of the review involved searching selected databases for randomized controlled trials which compared acyclovir to placebo in children and young adults under 25 years of age with a diagnosis of primary herpetic gingivostomatitis with or without herpes labialis.  [...] (Source: Bibby Library News and Tips)</description>
            <author>Bibby Library News and Tips</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2022775</comments>
            <pubDate>Mon, 08 Dec 2008 21:33:49 +0100</pubDate>
            <guid isPermaLink="false">2022775</guid>        </item>
    </channel>
</rss>

